Detalles de la búsqueda
1.
Plasma soluble fibrin monomer complex as a marker of coronary thrombotic events in patients with acute myocardial infarction.
Tohoku J Exp Med
; 219(1): 25-31, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19713681
2.
[Study on usefulness of different APTT test kit in variable coagulopathy].
Rinsho Byori
; 56(3): 195-202, 2008 Mar.
Artículo
en Japonés
| MEDLINE | ID: mdl-18411803
3.
Soluble fibrin monomer degradation products as a potentially useful marker for hypercoagulable states with accelerated fibrinolysis.
Clin Chim Acta
; 386(1-2): 38-45, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17803984
4.
Factor Xa inhibitors: new anti-thrombotic agents and their characteristics.
Front Biosci
; 11: 232-48, 2006 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16146728
5.
Molecular dynamics calculations of wild type vs. mutant protein C: relationship between binding affinity to endothelial cell protein C receptor and hereditary disease.
J Biomol Struct Dyn
; 24(3): 203-7, 2006 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17054378
6.
[Phosphatidylserine-dependent anti-prothrombin antibody as a new marker for the diagnosis of antiphospholipid syndrome].
Rinsho Byori
; 54(3): 256-62, 2006 Mar.
Artículo
en Japonés
| MEDLINE | ID: mdl-16637574
7.
Protein C Sapporo (protein C Glu 25 --> Lys): a heterozygous missense mutation in the Gla domain provides new insight into the interaction between protein C and endothelial protein C receptor.
Thromb Haemost
; 94(5): 942-50, 2005 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16363234
8.
Increase in plasma thrombin-activatable fibrinolysis inhibitor may not contribute to thrombotic tendency in antiphospholipid syndrome because of inhibitory potential of antiphospholipid antibodies toward TAFI activation.
Int J Hematol
; 91(5): 776-83, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20490730
9.
[Diagnostic approach to collagen disease based on the symptoms].
Nihon Naika Gakkai Zasshi
; 92(10): 1904-10, 2003 Oct 10.
Artículo
en Japonés
| MEDLINE | ID: mdl-14621577
10.
New therapeutic option for thromboembolism--dabigatran etexilate.
Expert Opin Pharmacother
; 9(14): 2509-17, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18778188
11.
One novel and one recurrent mutation in the PROS1 gene cause type I protein S deficiency in patients with pulmonary embolism associated with deep vein thrombosis.
Am J Hematol
; 81(10): 787-97, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16868938
Resultados
1 -
11
de 11
1
Próxima >
>>